For research use only
| Cat No. | ABC-TC0171 |
| Product Type | Human Melanoma Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Melanoma |
| Product Code | COLO-794, Human Melanoma Cell Line COLO-794, COLO 794, COLO794, COLO-0794, Human Malignant Melanoma Cells, Experimental Tumor Cells |
Human melanoma. Colo 794 was established from a 14 year old male patient with a malignant melanoma.
COLO-794 is a human melanoma cell line derived from a 14-year-old male patient with a malignant melanoma. Morphologically, melanoma cells like COLO-794 often display epithelioid or spindle-shaped features with variable pigmentation depending on melanin production. Melanoma cells generally show large nuclei, prominent nucleoli, and cytoplasmic melanin granules when pigmented. These cells show adherent growth properties. Molecular markers for melanoma cells typically include S100 and HMB-45. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | COLO-794, Human Melanoma Cell Line COLO-794, COLO 794, COLO794, COLO-0794, Human Malignant Melanoma Cells, Experimental Tumor Cells |
| Species | Human |
| Cat.No | ABC-TC0171 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Melanoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Melanoma Cell Lines |
COLO-794 is widely used in melanoma research, including studies on tumor biology and cellular mechanisms. As a classic model for melanoma research, this cell line is used to explore key mechanisms such as tumor proliferation, invasion, metastasis and drug resistance. In research, COLO-794 is used to study cellular responses to experimental compounds and investigational agents. In addition, characterization of the COLO 794 genetic profile supports studies of melanoma-related gene alterations and signaling pathways.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).